- Report
- November 2025
- 140 Pages
Europe
From €2871EUR$3,250USD£2,504GBP
- Report
- October 2025
- 84 Pages
Middle East
From €4285EUR$4,850USD£3,736GBP
- Report
- October 2025
- 90 Pages
North America
From €2871EUR$3,250USD£2,504GBP
- Report
- June 2025
- 89 Pages
North America
From €3048EUR$3,450USD£2,658GBP
- Report
- June 2025
- 81 Pages
Middle East, Africa
From €3048EUR$3,450USD£2,658GBP
- Report
- June 2025
- 97 Pages
Asia Pacific
From €3490EUR$3,950USD£3,043GBP
- Report
- June 2025
- 100 Pages
Europe
From €3490EUR$3,950USD£3,043GBP
- Report
- June 2025
- 90 Pages
United States
From €1766EUR$1,999USD£1,540GBP
- Report
- February 2025
- 95 Pages
North America
From €5296EUR$5,995USD£4,619GBP
- Report
- February 2025
- 111 Pages
Europe
From €5296EUR$5,995USD£4,619GBP
- Report
- February 2025
- 107 Pages
Asia Pacific
From €5296EUR$5,995USD£4,619GBP
- Report
- February 2025
- 236 Pages
United States
From €7063EUR$7,995USD£6,159GBP
- Report
- November 2023
- 127 Pages
Global
From €3976EUR$4,500USD£3,467GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €2385EUR$2,700USD£2,080GBP
€3180EUR$3,600USD£2,773GBP
- Report
- January 2023
- 127 Pages
Global
From €1988EUR$2,250USD£1,733GBP
- Report
- April 2021
Global
From €795EUR$900USD£693GBP
- Report
- March 2022
- 260 Pages
Global
From €3313EUR$3,750USD£2,889GBP
- Report
- February 2024
- 78 Pages
Global
From €2606EUR$2,950USD£2,273GBP
- Report
- February 2020
- 237 Pages
Global
From €2430EUR$2,750USD£2,119GBP
- Report
- February 2024
- 158 Pages
Global
From €4108EUR$4,650USD£3,582GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more